Literature DB >> 24107732

Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma.

Martin Wolley1, Richard D Gordon, Eduardo Pimenta, Nicholas Daunt, Gregory J Slater, Ashraf H Ahmed, Michael Stowasser.   

Abstract

OBJECTIVES: In primary aldosteronism, adrenal vein sampling (AVS) suggests unilateral aldosterone-producing adenoma (APA) when the aldosterone/cortisol (A/F) ratio is less than or equal to peripheral on one side and at least two times peripheral on the other. When A/F ratios are lower bilaterally than peripheral despite adequate samples (adrenal venous cortisol ≥3 times peripheral), we recommend repeat AVS. This study aimed to determine the frequency of this occurrence and outcomes in such cases.
METHODS: We performed a retrospective observational study of all cases of primary aldosteronism undergoing initial AVS over a 34-year period.
RESULTS: Initial AVS in 1397 patients returned satisfactory and discriminatory results in 1066 (76.3%) but 37 patients (2.6%) had adequate samples but bilateral A/F ratios no higher than peripheral. Of the 22 of these 37 who agreed to repeat AVS, 10 demonstrated unilateral aldosterone production, and eight of these had unilateral adrenalectomy disclosing APAs and resulting in cure (3) or improvement (5) in hypertension. Eight had bilateral aldosterone production. Four studies were inconclusive. Patients with initial unsatisfactory AVS because of bilaterally low A/F ratios had significantly (P=0.023) more unilateral disease [10 of 18 satisfactory repeat studies (55.6%) vs. 326 of 1066 satisfactory initial studies (30.6%)] and a significantly higher (67.6 vs. 49.9%, P=0.034) percentage of males.
CONCLUSION: As the incidence of APAs was high in a subgroup with low A/F bilaterally on initial AVS, these patients should be offered repeat AVS. This might reflect both a greater dependence of aldosterone production on adrenocorticotrophic hormone (ACTH) in APAs and the pulsatile nature of ACTH secretion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24107732     DOI: 10.1097/HJH.0b013e328362add3

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

1.  Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling.

Authors:  Yuichi Fujii; Hironobu Umakoshi; Norio Wada; Takamasa Ichijo; Kohei Kamemura; Yuichi Matsuda; Tatsuya Kai; Tomikazu Fukuoka; Ryuichi Sakamoto; Atsushi Ogo; Tomoko Suzuki; Kazutaka Nanba; Mika Tsuiki; Mitsuhide Naruse
Journal:  J Hum Hypertens       Date:  2017-11-24       Impact factor: 3.012

2.  Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea.

Authors:  M J Wolley; E Pimenta; D Calhoun; R D Gordon; D Cowley; M Stowasser
Journal:  J Hum Hypertens       Date:  2017-04-06       Impact factor: 3.012

Review 3.  New Advances in the Diagnostic Workup of Primary Aldosteronism.

Authors:  Martin J Wolley; Michael Stowasser
Journal:  J Endocr Soc       Date:  2017-01-27

4.  The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism.

Authors:  Yui Shibayama; Norio Wada; Mitsuhide Naruse; Isao Kurihara; Hiroshi Ito; Takashi Yoneda; Yoshiyu Takeda; Hironobu Umakoshi; Mika Tsuiki; Takamasa Ichijo; Hisashi Fukuda; Takuyuki Katabami; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Yuichi Ohno; Masakatsu Sone; Megumi Fujita; Katsutoshi Takahashi; Hirotaka Shibata; Kohei Kamemura; Yuichi Fujii; Koichi Yamamoto; Tomoko Suzuki
Journal:  J Endocr Soc       Date:  2018-03-22

5.  Adrenal Vein Sampling With Gadolinium Contrast Medium in a Patient With Florid Primary Aldosteronism and Iodine Allergy.

Authors:  Yuichi Yoshida; Satoshi Nagai; Kanako Shibuta; Shuhei Miyamoto; Miyuki Maruno; Ryo Takaji; Shinro Hata; Haruto Nishida; Shotaro Miyamoto; Yoshinori Ozeki; Mitsuhiro Okamoto; Koro Gotoh; Takayuki Masaki; Toshitaka Shin; Hiromitsu Mimata; Tsutomu Daa; Yoshiki Asayama; Hirotaka Shibata
Journal:  J Endocr Soc       Date:  2022-01-27

6.  Validation of three novel clinical prediction tools for primary aldosteronism subtyping.

Authors:  Tomaž Kocjan; Gaj Vidmar; Peter Popović; Milenko Stanković
Journal:  Endocr Connect       Date:  2022-05-11       Impact factor: 3.221

7.  Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism.

Authors:  Hironobu Umakoshi; Mika Tsuiki; Maki Yokomoto-Umakoshi; Yoshiyu Takeda; Yoneda Takashi; Isao Kurihara; Hiroshi Itoh; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Kenji Ashida; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Yuichi Fujii; Koichi Yamamto; Atsushi Ogo; Shintaro Okamura; Shozo Miyauchi; Tomikazu Fukuoka; Shoichiro Izawa; Toshihiko Yanase; Shigeatsu Hashimoto; Masanobu Yamada; Yuichiro Yoshikawa; Tatsuya Kai; Tomoko Suzuki; Takashi Kawamura; Mitsuhide Naruse
Journal:  J Endocr Soc       Date:  2018-05-24

8.  Bilateral Aldosterone Suppression in Patients With Right Unilateral Primary Aldosteronism and Review of the Literature.

Authors:  Sarah Ying Tse Tan; Keng Sin Ng; Colin Tan; Matthew Chuah; Meifen Zhang; Troy H Puar
Journal:  J Endocr Soc       Date:  2020-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.